A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Chandigarh: Neuro-ophthalmology conference (NCNO-2025) at PGI concluded on Monday with a series of groundbreaking ...

A study reveals a heightened cancer risk in patients with CVT, particularly in the first year and up to 10 years.

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

For hundreds of years, people have turned to chocolate to boost heart health. Back in the 1500s, the indigenous Aztec people ...

Novartis to buy Boston-based clinical-stage biopharma company Anthos Therapeutics for up to $3.1 billion: Basel Tuesday, February 11, 2025, 17:45 Hrs [IST] Novartis announced that ...

Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront ...

Novartis (NVS) announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, ...

Basel: Novartis today announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, ...